Clinical and pharmacokinetic evaluation of risperidone for the management of autism spectrum disorder-Reference-Cited by-同舟云学术

Clinical and pharmacokinetic evaluation of risperidone for the management of autism spectrum disorder

Published:2014-11-11 Issue:1 Volume:11 Page:111-124
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Dinnissen Mariken¹,Dietrich Andrea¹,van den Hoofdakker Barbara J¹,Hoekstra Pieter J¹

Affiliation:

1. University of Groningen, University Medical Center Groningen, Department of Child and Adolescent Psychiatry, Hanzeplein 1, 9713 GZ Groningen, The Netherlands ; ;

Publisher

Informa Healthcare

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/17425255.2015.981151

Reference90 articles.

1. Prevalence of autism-spectrum conditions: UK school-based population study

2. Epidemiology of Autism Spectrum Disorders in Adults in the Community in England

3. Prevalence of Autism Spectrum Disorders in a Total Population Sample

4. IQ in children with autism spectrum disorders: data from the Special Needs and Autism Project (SNAP)

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TAAR1 and 5-HT1B receptor agonists attenuate autism-like irritability and aggression in rats prenatally exposed to valproic acid;Pharmacology Biochemistry and Behavior;2024-12

2. Association of Parental Support with Reduced Stereotypy in Children with Autism Spectrum Disorder: A Cross-Sectional Study;Medicina;2023-09-15

3. Trackers for Adverse Events in Child Mental Health: descriptive analysis using the global trigger tool;Brazilian Journal of Pharmaceutical Sciences;2023

4. Children and Adolescents;The Maudsley Prescribing Guidelines in Psychiatry;2021-12-17

5. Practitioner’s review: medication for children and adolescents with autism spectrum disorder (ASD) and comorbid conditions;neuropsychiatrie;2021-06-23